SynthesisClinical rheumatology2026
Seasonal and geographic variations in vitamin D levels among patients with familial Mediterranean fever: a systematic review and meta-analysis.
Synthesis in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFamilial Mediterranean fever (FMF) is an autoinflammatory condition caused by a single-gene mutation, inherited in an autosomal recessive pattern, and characterized by recurrent episodes of self-limited inflammation. Studies suggest that vitamin D levels may be lower in FMF patients, but evidence remains unclear. This study aims to assess the relationship between FMF and serum vitamin D levels.
methodWe followed PRISMA guidelines and registered the protocol in PROSPERO (CRD420261299635). We searched PubMed, Scopus, and Web of Science up to December 2025 for observational studies comparing FMF patients with healthy controls. Our main outcomes were serum 25-hydroxyvitamin D, parathyroid hormone (PTH), and C-reactive protein (CRP). We combined the data as mean differences using a random-effects model.
resultTen studies (563 FMF patients) were included. The pooled analysis showed a significant drop in vitamin D levels in FMF patients compared to healthy controls. However, there was high heterogeneity between studies (I
conclusionSeasonal and regional factors play a significant role in determining vitamin D levels among FMF patients, with lower levels observed in winter and in Egyptian patients. Because of the high heterogeneity and low certainty, larger studies are needed to confirm the findings. Key Points • The first meta-analysis to compare vitamin D level between FMF patients and healthy individuals, findings show severe deficit in vitamin D level. • Many factors contribute to this decrease in vitamin D, starting from seasonal and geographical distribution and autoinflammatory state of FMF, making the fact of low vitamin D among FMF patients is highly individualized according to these prescribed factors. • Despite vitamin D deficit, there is no significant difference in PTH or CRP level.
Indexed as
Identifiers
42120817What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.